RecruitingNCT05767697

Genomics and Prognosis in GI Cancers

Explore the Correlation of Genomics and Prognosis in Alimentary Tract Cancers


Sponsor

National Health Research Institutes, Taiwan

Enrollment

1,000 participants

Start Date

Apr 15, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to collect biospecimens and explore the correlation of genomics and prognosis in alimentary tract cancers.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tissue and blood samples from patients with gastrointestinal (GI) cancers to study how genetic changes relate to prognosis and treatment outcomes. It covers pancreatic, esophageal, stomach, liver, bile duct, and colorectal cancers. **You may be eligible if...** - You are 20 years old or older - You have a confirmed diagnosis of one of the following: pancreatic cancer, esophageal cancer, gastric (stomach) cancer, liver cancer (hepatocellular carcinoma), bile duct cancer (cholangiocarcinoma), or colorectal cancer - You are willing to provide tumor tissue samples and blood samples for research - You can sign an informed consent form **You may NOT be eligible if...** - You are unable or unwilling to provide blood samples Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

National Cheng-Kung University Hospital

Tainan, Taiwan

National Institute of Cancer Research

Tainan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05767697


Related Trials